In 2008, Young and colleagues reported the potential diagnostic utility of VEGF-D levels for women with cystic lung disease of unknown etiology as elevated VEGF-D levels were associated with LAM [4], but not healthy women or women with other lung diseases. This evidence concerns the gene VEGFD and lymphangioleiomyomatosis.